Stereotaxis (STXS) Capital Expenditures Growth (3y) (2014 - 2026)
Stereotaxis (STXS) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.80 Bn | 43.99 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.03 Bn | 31.37 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.85 Bn | 30.62 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.39 Bn | 27.73 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | -21.70% |
| 10 | Stereotaxis | 131.53 Mn | 116.91 Mn | 3.79 Mn | -39.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.06% |
| Dec 31, 2025 | -42.54% |
| Mar 31, 2025 | -72.89% |
| Dec 31, 2024 | -88.13% |
| Sep 30, 2024 | -41.90% |
| Dec 31, 2022 | 200.09% |
| Sep 30, 2022 | 224.51% |
| Mar 31, 2022 | 389.60% |
| Dec 31, 2021 | 393.88% |
| Sep 30, 2021 | -36.45% |
| Jun 30, 2021 | 35.26% |
| Mar 31, 2021 | 50.42% |
| Dec 31, 2018 | -52.63% |
| Sep 30, 2018 | 200.01% |
| Mar 31, 2018 | -42.45% |
| Dec 31, 2017 | -50.07% |
| Sep 30, 2017 | 118.48% |
| Dec 31, 2015 | 439.11% |
| Sep 30, 2015 | -24.46% |
| Mar 31, 2015 | -13.96% |